期刊文献+

miRNA在肺癌筛查、诊断、治疗及预后中的应用价值 被引量:1

The Value of Mirna in the Screening,Diagnosis,Treatment and Prognosis of Lung Cancer
在线阅读 下载PDF
导出
摘要 miRNA(MicroRNAs)是一类具有调节靶基因表达的18-25个短核甘酸序列组成的非编码核糖核苷酸分子。miRNA在机体的正常发育及病理过程中发挥极其重要的生物学功能。目前我国肺癌发病率日益上升,肺癌的早期诊断及治疗却面临着极大地困难。大量临床研究表明,miRNA在肺癌的筛查、诊断、治疗及预后中起着重要的应用价值。 MiRNA(MicroRNAs)is a class of small non-coding RNAs(18nt^25nt)that regulate the expression of target genes.MiRNA plays key roles in normal development and pathological processes of body.At present,lung cancer has been rapidly rising inincidence in china,but the early diagnosis and treatment of early-stage lung cancer are facing great difficulties.Many clinical studiesshowed that miRNA has important value in the screening,diagnosis treatment and prognosis of lung cancer.
作者 王晓琼 张玲玲 王江洪 孙岩 WANG Xiao-qiong;ZHANG Ling-ling;WANG Jiang-hong;SUN Yan(Medical College, Zhengzhou University of Industrial Technology, Xinzheng 451150, China)
出处 《唐山师范学院学报》 2017年第5期65-68,共4页 Journal of Tangshan Normal University
关键词 MIRNA 肺癌 筛查 诊断 治疗 预后 miRNA lung cancer screening diagnosis treatment prognosis
作者简介 王晓琼(1988-),女,河南三门峡人,硕士,助教,研究方向为分子生物学
  • 相关文献

参考文献4

二级参考文献85

  • 1刘伦旭,李为民,李潞,李娟,周清华.吉非替尼(Iressa)治疗复发性非小细胞肺癌[J].中国肺癌杂志,2004,7(4):321-324. 被引量:14
  • 2Jemal A, Tiwari RC, Murray T, et al. Cancer statistics. CA Cancer J Clin,2004, 54(1): 8-29.
  • 3Rusch V, Baselga J, Cordon-Cardo C, et al. Differential expression of the epidermal growth factor receptor and its ligands in primary non-smaU cell lung cancers and adjacent benign lung. Cancer Res, 1993, 53(10 Suppl): 2379-2385.
  • 4Ciardiello F, Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res, 2001, 7(10): 2958-2970.
  • 5PaezJG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 2004, 304(5676): 1497-1500.
  • 6Morgillo F, Kim WY, Kim ES, et al. Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib. Clin Cancer Res, 2007, 13 (9): 2795-2803.
  • 7Riely G J, politi KA, Miller VA, et al. Update on epidermal growth factor receptor mutations in non-small cell lung cancer. Clin Cancer Res, 2006, 12(24): 7232-7241.
  • 8Tracy S, Mukohara T, Hansen M, et al. Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255. Cancer Res, 2004, 64(20): 7241-7244.
  • 9Hoshi S, Yamaguchi T, Kono C, et al. Recurrence of non-small cell lung cancer after successful treatment with gefitinib-report of three cases. Gan To Kagaku Ryoho, 2004, 31(8): 1209-1213.
  • 10Xu Y, Chen J, Zhou Q, et al. Acquired resistance of lung adenocarcinoma to EGFR-tyrosine kinase inhibitors gefitinib and erlotinib. Cancer Biol Ther, 2010, 9(8): 572-582.

共引文献172

同被引文献12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部